VLDLR Antikörper (AA 133-247)
Kurzübersicht für VLDLR Antikörper (AA 133-247) (ABIN7175437)
Target
Alle VLDLR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 133-247
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Very low-density lipoprotein receptor protein (133-247AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
-
Andere Bezeichnung
- VLDLR
-
Hintergrund
-
Background: Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity).
Aliases: FLJ35024 antibody, Very low density lipoprotein receptor antibody, Very low-density lipoprotein receptor antibody, VLDL R antibody, VLDL receptor antibody, VLDL-R antibody, VLDLR antibody, VLDLR_HUMAN antibody, VLDLRCH antibody
-
UniProt
- P98155
-
Pathways
- Cellular Response to Molecule of Bacterial Origin
Target
-